Sign in

CIK 0000014272

  • Large accelerated filer

BRISTOL MYERS SQUIBB CO

Sign in to watch
Ticker
BMY
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
220790350
Phone
+1 609-252-4621
Business address
ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543

Securities

  • BMY Bristol-Myers Squibb Company Common Stock NYSE
  • CELG-RI Rights NYSE
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$677,826
in 3 filings

Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-02-01 Storch Gerald L Director Grant or award · Deferred Share Units +3,054.17 $62.21 $190K 63,156.79
2021-02-01 Paliwal Dinesh C Director Grant or award · Deferred Share Units +3,054.17 $62.21 $190K 39,887.3
2021-02-01 Rice Derica W Director Grant or award · Deferred Share Units +3,054.17 $62.21 $190K 4,999.56
2021-02-01 Samuels Theodore R. II Director Grant or award · Deferred Share Units +3,054.17 $62.21 $190K 24,644.82
2021-02-01 BONNEY MICHAEL W Director Grant or award · Deferred Share Units +3,054.17 $62.21 $190K 8,564.74
2020-12-31 VESSEY RUPERT EVP, Research & Early Dev. Exercise or conversion +25,866 68,074
2020-12-31 VESSEY RUPERT EVP, Research & Early Dev. Shares withheld for taxes −13,257 $62.03 $822K 54,817
2020-12-31 VESSEY RUPERT EVP, Research & Early Dev. Exercise or conversion · Restricted Stock Units −25,866 0
2020-12-31 Elkins David V EVP, Chief Financial Officer Exercise or conversion +20,624 79,111
2020-12-31 Elkins David V EVP, Chief Financial Officer Shares withheld for taxes −11,931 $62.03 $740K 67,180
2020-12-31 Elkins David V EVP, Chief Financial Officer Exercise or conversion · Restricted Stock Units −20,624 0
2020-12-31 AHMED NADIM EVP and President, Hematology Exercise or conversion +14,946 46,549
2020-12-31 AHMED NADIM EVP and President, Hematology Shares withheld for taxes −7,660 $62.03 $475K 38,889
2020-12-31 AHMED NADIM EVP and President, Hematology Exercise or conversion · Restricted Stock Units −14,946 0
2020-12-31 YALE PHYLLIS R Director Grant or award · Deferred Share Units +463.49 $62.03 $29K 5,909.07
2020-12-31 Vousden Karen H Director Grant or award · Deferred Share Units +156.17 $62.03 $10K 14,609.85
2020-12-31 Storch Gerald L Director Grant or award · Deferred Share Units +564.24 $62.03 $35K 59,632.91
2020-12-31 Samuels Theodore R. II Director Grant or award · Deferred Share Units +523.94 $62.03 $32K 21,421.91
2020-12-31 Rice Derica W Director Grant or award · Deferred Share Units +463.49 $62.03 $29K 1,930.19
2020-12-31 Price Paula A Director Grant or award · Deferred Share Units +115.87 $62.03 $7K 1,469.67

Page 85 of 90 · 1,795 trades